Merit Medical Systems (NASDAQ:MMSI) Stock Price Target Raised at Wells Fargo & Company

Merit Medical Systems (NASDAQ:MMSI) had its target price hoisted by stock analysts at Wells Fargo & Company from $83.00 to $92.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 6.54% from the stock’s current price.

MMSI has been the subject of several other reports. Zacks Research cut shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 19th. Bank of America upped their price target on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. Needham & Company LLC increased their price target on Merit Medical Systems from $101.00 to $106.00 and gave the stock a “buy” rating in a report on Friday. Weiss Ratings raised Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, October 12th. Finally, Canaccord Genuity Group set a $121.00 price objective on Merit Medical Systems in a research note on Friday. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $104.18.

Merit Medical Systems Price Performance

Shares of Merit Medical Systems stock traded down $7.04 during trading on Friday, reaching $86.36. 723,826 shares of the company’s stock were exchanged, compared to its average volume of 787,708. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. Merit Medical Systems has a 1-year low of $59.74 and a 1-year high of $94.85. The company has a market cap of $5.16 billion, a P/E ratio of 35.70, a PEG ratio of 2.30 and a beta of 0.51. The firm’s 50-day moving average price is $88.68 and its 200 day moving average price is $77.12.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.08. The business had revenue of $416.24 million during the quarter, compared to analysts’ expectations of $410.56 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.92 EPS. As a group, research analysts anticipate that Merit Medical Systems will post 3.84 earnings per share for the current year.

Hedge Funds Weigh In On Merit Medical Systems

Several large investors have recently bought and sold shares of the stock. Kilter Group LLC purchased a new stake in shares of Merit Medical Systems during the second quarter valued at approximately $25,000. Salomon & Ludwin LLC grew its holdings in Merit Medical Systems by 140.8% during the third quarter. Salomon & Ludwin LLC now owns 537 shares of the medical instruments supplier’s stock valued at $46,000 after purchasing an additional 314 shares during the period. IFP Advisors Inc grew its holdings in Merit Medical Systems by 88.6% during the third quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier’s stock valued at $60,000 after purchasing an additional 326 shares during the period. Harbor Investment Advisory LLC purchased a new stake in Merit Medical Systems in the second quarter worth $50,000. Finally, Pinnacle Wealth Planning Services Inc. raised its stake in shares of Merit Medical Systems by 84.0% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 784 shares of the medical instruments supplier’s stock valued at $68,000 after buying an additional 358 shares during the period. 99.66% of the stock is currently owned by institutional investors.

Key Headlines Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Third-quarter results exceeded expectations. Revenue increased 8.4% year over year to $416.2 million, surpassing the $410.6 million consensus estimate. Adjusted EPS was $1.12 versus expectations of $1.04 and $0.92 a year earlier. GAAP EPS rose 51% to $0.70, while GAAP and adjusted operating margins also improved. Merit Medical Reports Third Quarter 2026 Results
• Positive Sentiment: Management raised full-year 2026 earnings guidance. The outlook increase indicates confidence in continued profitability and follows 9% organic constant-currency revenue growth in the quarter. Year-to-date operating cash flow was $175.2 million and free cash flow was $129.5 million, supporting financial flexibility. Merit Medical Raises 2026 Earnings Guidance
• Positive Sentiment: Analysts increased their price targets. BTIG Research raised its target from $105 to $110 and assigned a Buy rating, while other analysts reportedly lifted targets to $106 and $110. These revisions suggest the earnings beat and improved outlook could support additional upside. Analysts Boost Forecasts After Strong Q3 Results
• Positive Sentiment: Merit expanded its cardiac therapies business. The acquisition of Solo Pace adds temporary pacing technology used in transcatheter aortic valve replacement procedures, potentially broadening the company’s cardiac product portfolio. Financial terms were not disclosed. Merit Medical Acquires Solo Pace
• Neutral Sentiment: Coverage is mixed. Freedom Capital initiated coverage with a Hold rating, contrasting with BTIG’s Buy recommendation. At roughly 36 times earnings, MMSI’s valuation leaves less room for execution or guidance disappointments.
• Negative Sentiment: The sales outlook was narrowed. Although earnings guidance increased, analysts noted that Merit narrowed its full-year revenue outlook. That may have tempered enthusiasm and contributed to pressure on the shares despite the quarterly beat. Merit Medical Lifted Guidance

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.